Login / Signup

Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC.

Thomas LongvalAnne-Claire LeprêtreAurélie RavinetAmandine FayardEdouard ForcadeTereza ComanRabah RedjoulAna BerceanuNimrod BuchbinderGuillaume BerlieMaria MappouraFederica GiannottiFlorian ChevillonMarie RobinRégis Peffault de LatourFlore Sicre de Fontbrunenull null
Published in: Bone marrow transplantation (2024)
Keyphrases
  • single cell
  • multiple myeloma
  • stem cells
  • combination therapy
  • hematopoietic stem cell
  • bone marrow